Antigenic_JJ
specificities_NNS
of_IN
human_JJ
CD4_NN
+_CC
T-cell_NN
clones_NNS
recovered_VBD
from_IN
recurrent_JJ
genital_JJ
herpes_NN
simplex_NN
virus_NN
type_NN
2_CD
lesions_NNS
._.

Lesions_NNS
resulting_VBG
from_IN
recurrent_JJ
genital_JJ
herpes_NN
simplex_NN
virus_NN
-LRB-_-LRB-
HSV_NN
-RRB-_-RRB-
infection_NN
are_VBP
characterized_VBN
by_IN
infiltration_NN
of_IN
CD4_NN
+_CC
lymphocytes_NNS
._.

We_PRP
have_VBP
investigated_VBN
the_DT
antigenic_JJ
specificity_NN
of_IN
47_CD
HSV-specific_JJ
CD4_NN
+_CC
T-cell_NN
clones_NNS
recovered_VBN
from_IN
the_DT
HSV-2_NN
buttock_NN
and_CC
thigh_NN
lesions_NNS
of_IN
five_CD
patients_NNS
._.

Clones_NNS
with_IN
proliferative_JJ
responses_NNS
to_TO
recombinant_JJ
truncated_VBN
glycoprotein_NN
B_NN
-LRB-_-LRB-
gB_NN
-RRB-_-RRB-
or_CC
gD_NN
of_IN
HSV-2_NN
or_CC
purified_VBN
natural_JJ
gC_NN
of_IN
HSV-2_NN
comprised_VBD
a_DT
minority_NN
of_IN
the_DT
total_JJ
number_NN
of_IN
HSV-specific_JJ
clones_NNS
isolated_VBN
from_IN
lesions_NNS
._.

The_DT
gC2_NN
-_:
and_CC
gD2-specific_JJ
CD4_NN
+_CC
clones_NNS
had_VBD
cytotoxic_JJ
activity_NN
._.

The_DT
approximate_JJ
locations_NNS
of_IN
the_DT
HSV-2_NN
genes_NNS
encoding_VBG
HSV-2_NN
type-specific_JJ
CD4_NN
+_JJ
antigens_NNS
have_VBP
been_VBN
determined_VBN
by_IN
using_VBG
HSV-1_NN
x_NN
HSV-2_NN
intertypic_JJ
recombinant_JJ
virus_NN
and_CC
include_VBP
the_DT
approximate_JJ
map_NN
regions_NNS
0.30_CD
to_TO
0.46_CD
,_,
0.59_CD
to_TO
0.67_CD
,_,
0.67_CD
to_TO
0.73_CD
,_,
and_CC
0.82_CD
to_TO
1.0_CD
units_NNS
._.

The_DT
antigenic_JJ
specificity_NN
of_IN
an_DT
HLA_NN
DQ2-restricted_JJ
,_,
HSV-2_NN
type-specific_JJ
T-cell_NN
clone_NN
was_VBD
mapped_VBN
to_TO
amino_NN
acids_NNS
425_CD
to_TO
444_CD
of_IN
VP16_NN
of_IN
HSV-2_NN
by_IN
sequential_JJ
use_NN
of_IN
an_DT
intertypic_JJ
recombinant_JJ
virus_NN
containing_VBG
VP16_NN
of_IN
HSV-2_NN
in_IN
an_DT
HSV-1_NN
background_NN
,_,
recombinant_JJ
VP16_NN
fusion_NN
proteins_NNS
,_,
and_CC
synthetic_JJ
peptides_NNS
._.

Each_DT
of_IN
the_DT
remaining_VBG
four_CD
patients_NNS
also_RB
yielded_VBD
at_IN
least_JJS
one_CD
type-specific_JJ
T-cell_NN
clone_NN
reactive_JJ
with_IN
an_DT
HSV-2_NN
epitope_NN
mapping_NN
to_TO
approximately_RB
0.67_CD
to_TO
0.73_CD
map_NN
units_NNS
._.

The_DT
antigenic_JJ
specificities_NNS
of_IN
lesion-derived_JJ
CD4_NN
+_CC
T-cell_NN
clones_NNS
are_VBP
quite_RB
diverse_JJ
and_CC
include_VBP
at_IN
least_JJS
10_CD
epitopes_NNS
._.

Human_JJ
T-cell_NN
clones_NNS
reactive_JJ
with_IN
gC_NN
and_CC
VP16_NN
are_VBP
reported_VBN
here_RB
for_IN
the_DT
first_JJ
time_NN
._.

